Free Trial
NASDAQ:UPB

Upstream Bio (UPB) Stock Price, News & Analysis

Upstream Bio logo
$15.50 -0.11 (-0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$15.38 -0.12 (-0.77%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Upstream Bio Stock (NASDAQ:UPB)

Key Stats

Today's Range
$15.45
$16.06
50-Day Range
$9.15
$15.61
52-Week Range
$5.14
$29.46
Volume
359,635 shs
Average Volume
457,920 shs
Market Capitalization
$833.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.50
Consensus Rating
Buy

Company Overview

Upstream Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

UPB MarketRank™: 

Upstream Bio scored higher than 31% of companies evaluated by MarketBeat, and ranked 1319th out of 1,836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Upstream Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Upstream Bio has received no research coverage in the past 90 days.

  • Read more about Upstream Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Upstream Bio are expected to grow in the coming year, from ($4.30) to ($2.37) per share.

  • Price to Book Value per Share Ratio

    Upstream Bio has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Upstream Bio's valuation and earnings.
  • Short Interest

    There is no current short interest data available for UPB.
  • Dividend Yield

    Upstream Bio does not currently pay a dividend.

  • Dividend Growth

    Upstream Bio does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for UPB.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Upstream Bio this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for UPB on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Upstream Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.56% of the stock of Upstream Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Upstream Bio's insider trading history.
Receive UPB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Upstream Bio and its competitors with MarketBeat's FREE daily newsletter.

UPB Stock News Headlines

Upstream Bio (UPB) Expected to Announce Earnings on Tuesday
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Upstream Bio begins phase 2 COPD trial for verekitug
See More Headlines

UPB Stock Analysis - Frequently Asked Questions

Upstream Bio's stock was trading at $16.44 on January 1st, 2025. Since then, UPB shares have decreased by 5.7% and is now trading at $15.50.

Upstream Bio, Inc. (NASDAQ:UPB) posted its earnings results on Tuesday, May, 6th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.49) by $0.02. The company had revenue of $0.57 million for the quarter, compared to analyst estimates of $0.71 million.

Upstream Bio (UPB) raised $200 million in an initial public offering on Friday, October 11th 2024. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. JPMorgan, TD Cowen, Piper Sandler and William Blair acted as the underwriters for the IPO.

Upstream Bio's top institutional investors include CWM LLC (0.01%). Insiders that own company stock include Erez Chimovits and Ai Upstream Llc.
View institutional ownership trends
.

Shares of UPB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/06/2025
Today
8/05/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:UPB
Previous Symbol
NASDAQ:UPB
CIK
2022626
Fax
N/A
Employees
38
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$38.00
Potential Upside/Downside
+255.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
47.43
Quick Ratio
47.43

Sales & Book Value

Annual Sales
$2.30 million
Price / Sales
372.53
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.77 per share
Price / Book
1.81

Miscellaneous

Outstanding Shares
53,794,000
Free Float
46,500,000
Market Cap
$855.32 million
Optionable
N/A
Beta
N/A

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:UPB) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners